Clinical Trials Sponsored by Pacific Pharmaceuticals
Total 19879 results
-
Alnylam PharmaceuticalsRecruitingType 2 Diabetes Mellitus (T2DM)Canada, United States
-
CStone PharmaceuticalsNot yet recruitingExtranodal NK/T-cell Lymphoma
-
ASLAN PharmaceuticalsRecruitingAtopic DermatitisUnited States, Canada
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkins Lymphoma (B-NHL)United States, United Kingdom
-
Vanda PharmaceuticalsRecruitingSchizophrenia | Bipolar I DisorderUnited States
-
Jazz PharmaceuticalsRecruitingParkinson Disease | TremorUnited States, Spain, Germany, Poland
-
Regeneron PharmaceuticalsRecruiting
-
Jazz PharmaceuticalsRecruitingSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
Regeneron PharmaceuticalsRecruitingNon-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)United States, Korea, Republic of, Puerto Rico, Japan
-
Sparrow PharmaceuticalsRecruitingPolymyalgia RheumaticaGermany
-
Sparrow PharmaceuticalsRecruitingAutonomous Cortisol Secretion (ACS) | ACTH-Independent Cushing Syndrome | ACTH-Independent Adrenal Cushing Syndrome, SomaticUnited States, United Kingdom, France, Romania
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
CStone PharmaceuticalsRecruitingGastrointestinal Stromal TumorsChina
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerGermany, Austria, France
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Spain, Germany, Mexico, Turkey, Canada, Austria, Netherlands, United Kingdom, Italy, Georgia, France, Brazil, Romania, Czechia, Argentina, Australia, Ireland, Chile, Hungary, South Africa, Belgium, Poland, Peru
-
ORIC PharmaceuticalsRecruitingPh 1/2 Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationSolid TumorsKorea, Republic of, United States, Australia, Canada
-
Arrowhead PharmaceuticalsRecruitingChronic Obstructive Pulmonary Disease | AsthmaKorea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
-
CStone PharmaceuticalsRecruitingAdvanced Solid Tumor | Advanced LymphomaChina, Australia, United States
-
Ferring PharmaceuticalsRecruitingInfertilityItaly, Spain, France, United Kingdom, Austria
-
Alnylam PharmaceuticalsRecruitingEarly-Onset Alzheimer DiseaseUnited Kingdom, United States, Netherlands, Canada
-
EOM PharmaceuticalsRecruitingCOVID-19 Pneumonia | COVID-19 Respiratory Infection | COVID-19 Acute Respiratory Distress SyndromeBrazil
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaMexico, Korea, Republic of, Turkey, Italy, United Kingdom, Thailand, Poland, Singapore, Spain, Taiwan, Canada, Japan, United States, Malaysia, Greece, Romania, Hungary
-
Jazz PharmaceuticalsRecruitingTuberous Sclerosis Complex | Dravet Syndrome | Lennox Gastaut SyndromeUnited States
-
Eledon PharmaceuticalsRecruitingKidney TransplantCanada, Australia, United Kingdom
-
Regeneron PharmaceuticalsRecruiting
-
Alnylam PharmaceuticalsRecruitingPrimary Hyperoxaluria Type 1France, Spain, United States, Israel, Belgium, Switzerland, Germany, United Kingdom, Italy, Canada
-
Jazz PharmaceuticalsRecruiting
-
Processa PharmaceuticalsRecruitingAdvanced Cancer | Refractory Cancer | Tumor GastricUnited States
-
Ferring PharmaceuticalsRecruiting
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid TumorsUnited States, Turkey
-
Regeneron PharmaceuticalsRecruiting
-
Alnylam PharmaceuticalsRecruitingTransthyretin-Mediated Amyloidosis | ATTR AmyloidosisIsrael, Italy, Netherlands, Spain, United States, France, Denmark, Germany, Portugal, Brazil, Taiwan
-
Marinus PharmaceuticalsRecruitingStatus EpilepticusUnited States, Australia, Canada
-
Vanda PharmaceuticalsRecruitingGastroparesis | Diabetic Gastroparesis | Idiopathic GastroparesisUnited States
-
Dizal PharmaceuticalsRecruitingNon-Small Cell Lung CancerSpain, Korea, Republic of, United States, Taiwan, France, Italy, Malaysia, Australia, Japan
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Regeneron PharmaceuticalsRecruiting
-
Vanda PharmaceuticalsRecruitingSleep Disturbances in Smith-Magenis SyndromeUnited States
-
Cumberland PharmaceuticalsRecruitingPathologic Processes | Skin Diseases | Autoimmune Diseases | Connective Tissue Diseases | Scleroderma, Systemic | Scleroderma, Diffuse | Scleroderma, Limited | Sclerosis, Progressive SystemicUnited States, India
-
BioCryst PharmaceuticalsTerminatedParoxysmal Nocturnal Hemoglobinuria | PNHUnited Kingdom, Austria, South Africa
-
Arrowhead PharmaceuticalsActive, not recruitingFamilial ChylomicronemiaKorea, Republic of, Canada, Australia, Singapore, Belgium, Spain, Japan, United States, Austria, Germany, Ireland, Oman, Poland, Israel, New Zealand, Argentina, France, Croatia, Mexico, Serbia, Turkey
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
Inovio PharmaceuticalsActive, not recruitingUrothelial CarcinomaUnited States, Spain
-
Regeneron PharmaceuticalsTerminated
-
Aerie PharmaceuticalsCompletedDry Eye DiseaseUnited States
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerUnited States, Korea, Republic of, Chile, Canada
-
Alnylam PharmaceuticalsCompletedAmyloidosis, Familial | Transthyretin AmyloidosisFrance, Germany, Italy, Portugal, Spain, Sweden, United Kingdom
-
Alnylam PharmaceuticalsActive, not recruitingHypertensionUnited States, Canada, United Kingdom, Puerto Rico, Ukraine
-
Primus PharmaceuticalsWithdrawnDiabetic UlcersUnited States